Rayence Co., Ltd. (KOSDAQ:228850)
6,650.00
+10.00 (0.15%)
At close: May 20, 2026
Rayence Revenue
In the year 2025, Rayence had annual revenue of 114.72B KRW, down -8.63%. Rayence had revenue of 29.13B in the quarter ending December 31, 2025, with 12.91% growth.
Revenue
114.72B
Revenue Growth
-8.63%
P/S Ratio
0.91
Revenue / Employee
512.16M
Employees
224
Market Cap
104.65B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 114.72B | -10.84B | -8.63% |
| Dec 31, 2024 | 125.56B | -17.42B | -12.18% |
| Dec 31, 2023 | 142.99B | -4.17B | -2.84% |
| Dec 31, 2022 | 147.16B | 12.59B | 9.36% |
| Dec 31, 2021 | 134.57B | 33.04B | 32.55% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Korea Parts & Fasteners Co.,Ltd | 743.91B |
| The Nature Holdings | 477.52B |
| XEXYMIX | 274.10B |
| Ray Co., Ltd. | 111.32B |
| Meta Biomed | 102.95B |
| Alphachips | 83.11B |
| JAS Robotics | 30.66B |
| Cytogen | 26.05B |